Wednesday, April 1, 2009

FDA and Social Media

Pin It Now!
This post on OnlineMediaDaily shows us another reason why big pharma has been reluctant to join the social media frenzy, fear of FDA regulations. While the Food & Drug Administration hasn't addressed any regulations on advertising on social media, there is still a fear that the FDA might not approve of the "message" being presented.

Dr. Jean Ah Kang, special assistant to Tom Abrams at the FDA's Division for Drug Marketing, even mentions that, "we do recognize the importance of social media, like Web 2.0, and we recognize that it is reality and it is here to stay." So it's obvious that there is potential for growth, but pharma will have to make it presents labeling information prominently and accurately and communicate all material risks in different social media platforms.
Post a Comment